Background. Severe cognitive impairment affects many patients with schizophrenia, especially geriatric in-patients. Little is known about the course of this impairment, however.
Method. Two hundred and twentyfour geriatric schizophrenic in-patients were examined for changes in cognitive functioning over a one-year follow-up period, and 45 of them were assessed over a two-year period. In addition, the subset of 45 patients participated in a one-week and one-month test-retest reliability study of the instrument used to assess cognitive impairment, the Mini-Mental State Examination (MMSE).
Results. The average MMSE scores did not change over a one-or two-year follow-up period. The testretest reliability of the scale was extremely good at both retest intervals.
Conclusion.
Among the implications of these data are that cognitive changes in geriatric schizophrenic patients are very slow and are more consistent with a neurodevelopmental process than a neurodegenerative course. B a c k g r o u n d . This study was undertaken to fill gaps in our knowledge of the rate of mood disorder in teenage girls in transition from school to further education, employment or unemployment.
Method. Girls aged 15-20 years (n=529) whose names were drawn from general practitioner age/ sex registers were interviewed at home and completed the Great Ormond Street Mood Questionnaire. Their mothers completed the 28-item General Health Questionnaire (GHQ). Social background variables were obtained.
Results. Of the girls, 20.8% scored over the cut-off point previously established to indicate risk of psychiatric disorder. Scoring over the cut-off point was not associated with age or parental social class.It was associated with parental separation1 divorce (P<0.004), with maternal self-report on the GHQ (Pc0.001), and with parental unemployment (Pc0.04). Lowest selfreport scores were obtained by girls who had left school and were in employment (P<O.Ol).
Conclusions. About one in five of girls aged 15-20 are at risk of affective disorder. Self reported mood disturbance is associated with a wide range of social and familial background variables, but not with age or parental socioeconomic status.
Predictors of
T r e a t m e n t Outcome in the Behavioural T r e a t m e n t Background. An investigation to determine which prognostic variables are associated with behavioural treatment failure in obsessive-compulsive disorder (OCD). Empirically established prognostic variables measured at the start of treatment may lead to adjusted treatment programmes for these patients.
Method. Forty patients, diagnosed with OCD, received a standardised treatment consisting of 18 sessions in vivo exposure and response prevention. Compulsive behaviour (MOCI) and obsessive fear (ADS) were the outcome measures. Prognostic variables included were initial severity of OC complaints, initial level of depression, problem duration, patients' motivation for treatment, quality of the therapeutic relationship, and marital dissatisfaction.
Results. Greater initial severity of complaints (P<0.01), and depression (P=0.03) predicted poorer outcome for compulsive behaviour. Greater initial severity of complaints (P<0.01), and the conjoint variables higher level of depression, longer problem duration, poorer motivation for treatment, and dissatisfaction with the therapeutic relationship predicted poorer outcome for obsessive fear (Pc0.01).
Conclusions. The complaintrelated variables of initial severity, initial depression, and problem duration, and the non-specific treatment variables of patients' motivation and quality of the therapeutic relationship, affect behavioural treatment outcome in OCD. [311] [312] [313] [314] [315] 1995 Background. In previous studies co1;nitive impairment in depressed elderly in-patients tends t o be associated wilh a late onset of depression. This study tests the hypothesis that cognitive impairment is associated with depression only in elderly individuals with no history of psychiatric illness.
Late-Life Depressive
Method. We investigated an agestratified sample of 4051 elderly people h i n g in Ule community, aged between 65 and 84 (AMSTEL). The relationship be tween depression (GMS-AGECAT diagnosis) and scores on the Mini Mental State Examination was studied in subjects with and without a report psychiatric history (CAMDEX qr lestionnaire).
Results. Method. A double-blind crossover study (2x8 weeks; n=34), interrupted by a two-week single-blind washout period, was employed. Assessments included the Schedule for Handicaps, Behaviour, and Skills (SHBS) and clinical Global Impression (CGI).
Results. The SHBS score was significantly reduced for the Zuclopenthixol cohort only. Endpoint analysis between the two drugs also showed and enhanced effect for zuclopenthixol over haloperiodol. CGI scores did not reveal significant difference between the two drugs.
Conclusion. Zuclopenthixol may be superior to haloperiodol for the treatment of behaviourd disturbances in mentally retarded subjects. Background. The economic burden of psychiatric disorders and learning disability is assessed in order to aid decisions on priorities for research finding.
The Prevalence and Costs of P s y c h i a t r i c D i s o r d e r s a n d Learning Disabilities
Method. A wide variety of data sources both on prevalence and on the usage of costs relevant services were used to measure the economic burden of each condition.
Results. Despite methodological problems and problems with the data, an attempt is made to estimate the relative economic burden imposed by each condition. No attempt is made to sum up the costs for each condition across the agencies and individual involved.
Conclusions. Our findings show that learning disability, schizophrenia and neurotic conditions (including depression) are major burdens on the National Health Service; senile dementia and depression in older people impact largely on local authority social services. Senile dementia, schizophrenia and learning disability are also heavy charges on the social security system. It is also notahle that the large numbers with less severely disabling neurotic disorders generate a burden that, according to our figures, is comparable to schizophrenia and other psychotic diso~ders.
Method. Individuals with at least ten admissions to non-psychiatric departments during an 8-year perid were studied. Persistent somatisers (n=56) were compared with other frequent users (n=57) of non-psychiatric services.
Results. Of the persistent somaLisers, 82% had been examined by a psychiatrist at least once (median, 3 times). Sixteen per cent were mentally retarded, 48% were dependent on alcohol or drugs, and 48% had DSM-111-R personality disorder. Tbe most prevalent ICD-10 diagnoses were anxiety states (54%), depression (30%). phobias (18%) and psychoses (20%).
Conclusions.Persistent somatisation is associated with severe mental illness and a broad specuum of heterogeneous psychiamc diagnoses and syndromes. Persistent somatisers impose a serious burden on the mental health care system.
Community
Attitudes t o Mental Illness By: Geoffrey Wolff, Soumitra Pathare, Tom Craig and JuIian Leff.British Journal of Psychiatry (1995). 166, 183-190.
Background. The baseline findigns from a controlled study of the effect of a public education campaign on community attitudes to mental illness are presented.
Method. A census of attitudes to mental illness was conducted in two areas, prior to the opening of supported houses for the mentally ill. Background. This study explores the incidence and nature of mental illness among persistent somatisers, and analyses their use of mental health services. of C;oodwill was educational level. The attilude factors were predictive of respondens' behavioural intentions toward the mentally ill. Respondents wid1 children and non-Caucasians were more likely to object to the mentally ill liviq in their neighbourhood.
Conclusions. Any intervention aimed at changing attitudes to mentally ill people in the community should be targ,eted at people with children and non-Caucasians, as these groups are more likely to object. Background. The new reversible MA01 moclobemide was compared with placebo in the treatment of elderly pa1:ients with DSM-I11 diagnosis of deinentia and / or of major depression.
Moclobemide in
Method. Six hundred and in~emational, multi-centre, double hlind trail in which they were randomly a1 ocated to treatment with either moclobemide 400 mg daily or placebo for 42 days. Five hundred and eleven patients met DSM-I11 criteria for dementia and were also depressed (DSM+D); 183 did not meet DSM-I11 criteria for dementia but met the criteria for DSM-111 maior denressive e~isode and also suffered from 'cognitive &cline (MDEKD).
Results. Analysis of the 17 and 24-item Hamilton Depression scale scores showed that moclobemide, compared with placebo, produced significantly greater improvement in cognitive function as measured by the SCAG Factor 1 in moclobemide treated patients (p= 0.005 DEM-D; P= 0.02 MDE+CD). There was no evidence of decline in cognitive function as the result of treatment. Clinical global assessment of tolerance was excellent and good in 88% of the moclobemide and in 92% of the placebo treated patients. THe proportion of patients discontinuing treatment prematurely was similar in both treatment groups. There were no significant, differences in sideeffects between treatment groups. There were no significant changes in vital signs, ECG or laboratory findings in either treatment group. There were no dietary restrictions and no report of any tyramine reaction.
Conclusions. Moclobemide was shown to be a safe, well tolerated and effective antidepressant, which did not cause impairment of cognitive function in elderly patients with a DSM-I11 diagnosis of dementia andlor DSM-111 major depression.
